Atea Pharma Proxy Solicitation Filing
Ticker: AVIR · Form: DEFA14A · Filed: Apr 1, 2025 · CIK: 1593899
| Field | Detail |
|---|---|
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
| Form Type | DEFA14A |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, corporate-governance
Related Tickers: ATEA
TL;DR
Atea Pharma (ATEA) is asking shareholders to vote on stuff via proxy. Check the details.
AI Summary
Atea Pharmaceuticals, Inc. filed a DEFA14A on April 1, 2025, related to a solicitation of proxies. The filing indicates that the company is seeking shareholder approval for matters to be discussed at an upcoming meeting, though specific proposals are not detailed in this excerpt. The company's principal executive offices are located at 225 Franklin Street, Suite 2100, Boston, MA 02110.
Why It Matters
This filing is important for shareholders as it outlines the company's request for proxy votes, which are crucial for corporate decision-making and governance.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not contain information that inherently increases investment risk.
Key Players & Entities
- Atea Pharmaceuticals, Inc. (company) — Filer
- 225 Franklin Street, Suite 2100, Boston, MA 02110 (company) — Principal Executive Offices
- April 1, 2025 (date) — Date of Report
FAQ
What is the purpose of this DEFA14A filing?
The DEFA14A filing is a definitive proxy statement used to solicit proxies from shareholders for an upcoming meeting, as indicated by the solicitation material pursuant to Rule 14a-12 under the Exchange Act.
When was this filing made?
This filing was made on April 1, 2025.
What is Atea Pharmaceuticals, Inc.'s principal executive office address?
Atea Pharmaceuticals, Inc.'s principal executive office is located at 225 Franklin Street, Suite 2100, Boston, MA 02110.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the Standard Industrial Classification code for Atea Pharmaceuticals, Inc.?
The Standard Industrial Classification code for Atea Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 1, 2025 regarding Atea Pharmaceuticals, Inc. (AVIR).